Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1

Interventions

Specimen Handling 67Magnetic Resonance Spectroscopy 54Biopsy 43pembrolizumab 35Carboplatin 32Nivolumab 30Radiotherapy 26Cyclophosphamide 26Cisplatin 26Radiation 25Paclitaxel 25olaparib 19Etoposide 18Taxes 17Radiotherapy, Intensity-Modulated 17Dexamethasone 17durvalumab 16Doxorubicin 16Disulfides 16Bevacizumab 16X-Rays 15Immunoglobulin G 15Platinum 14Docetaxel 14Cytarabine 14Vincristine 13Prednisone 13Pemetrexed 13Leucovorin 13Lenalidomide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Granulocyte-Macrophage Colony-Stimulating Factor × 30 days × Clear all
NCT03600350 2026-06-01

pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

University of Wisconsin, Madison

Phase 2 Active not recruiting
19 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT00458536 2026-05-19

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Beth Israel Deaconess Medical Center

Phase 1/2 Completed
38 enrolled 4 charts
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡